Earnings Releases

Edesa Biotech, Inc. reported the six months ended March 31, 2026 results: net income a net loss of $6.5 million, or $0.78 per common share, EPS $0.78 per common share.

“For the six months ended March 31, 2026, Edesa reported a net loss of $6.5 million, or $0.78 per common share, compared to a net loss of $3.2 million, or $0.74 per common share, for the six months ended March 31, 2025.”

Edesa Biotech, Inc. reported the three months ended March 31, 2026 results: net income a net loss of $4.2 million, or $0.49 per common share, EPS $0.49 per common share.

“For the quarter ended March 31, 2026, Edesa reported a net loss of $4.2 million, or $0.49 per common share, compared to a net loss of $1.6 million, or $0.30 per common share, for the quarter ended March 31, 2025.”

Falcon's Beyond Global, Inc. reported financial results for the fiscal quarter ended March 31, 2026.

“On May 14, 2026, Falcon’s Beyond Global, Inc. (the “Company”) issued a press release announcing its financial results for the fiscal quarter ended March 31, 2026. The full text of the Company’s press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K (this “Current Report”) and is incorporated herein by reference.”

Valion Bio, Inc. reported financial results for the three months ended March 31, 2026.

“Valion Bio Reports First Quarter 2026 Financial Results”

NeoVolta Inc. reported the quarter ended March 31, 2026 results: revenue $2.0 million, net income $3.0 million, or $(0.08) per share, EPS $(0.08) per share.

“half of fiscal 2026 gives us strong confidence in the path ahead.” - Ardes Johnson, Chief Executive Officer, NeoVolta. Third Quarter Fiscal 2026 Financial Highlights · Revenue: $2.0 million for Q3 FY2026, compared to $2.0 million in Q3 FY2025. Revenue in the quarter was impacted by a slowdown in the residential solar market following the expiration of the”

Gemini Space Station, Inc. reported financial results for the three months ended March 31, 2026.

“Gemini issued a press release (the "Q1 2026 Earnings Release") announcing its financial results for the three months ended March 31, 2026.”

Newton Golf Company, Inc. reported financial results for the first quarter ended March 31, 2026.

“On May 14, 2026, Newton Golf Company, Inc. (the “Company”) issued a press release, which is furnished as Exhibit 99.1 to this Current Report on Form 8-K, announcing its financial results for the quarter ended March 31, 2026.”

DILLARD'S, INC. reported financial results for 13 weeks ended May 2, 2026.

“Dillard’s, Inc. (NYSE: DDS) (the “Company” or “Dillard’s”) announced operating results for the 13 weeks ended May 2, 2026.”

Inuvo, Inc. reported first quarter ended March 31, 2026 results: net income net income of $1.9 million, or $0.13 per diluted share, EPS $0.13 per diluted share.

“During the first quarter of 2026, the Company generated net income of $1.9 million, or $0.13 per diluted share, compared with a net loss of $1.3 million, or $0.09 per diluted share, in the same period of 2025.”

HCW Biologics Inc. reported the three months ended March 31, 2026 results: revenue $6.5 million, net income $3.5 million.

“an in-kind payment of a transferable minority equity interest in Trimmune with a fair value of $3.5 million. For the three months ended March 31, 2026, the Company recognized $6.5 million in revenue and $470,000 in deferred revenue. Commercial-Ready Molecules Used as Reagents On March 13, 2026, Science Advances, a peer-reviewed, high-impact journal, released a”

authID Inc. reported first quarter ended March 31, 2026 results: revenue $0.5 million, net income $4.5 million, EPS $0.28.

“reported financial and operating results for the Quarter ended March 31, 2026. First Quarter 2026 vs. First Quarter 2025 Financial Summary ● Total revenue for the quarter was $0.5 million, compared to $0.3 million a year ago. ● Operating expenses were $5.0 million, compared to $4.7 million a year ago. ● Net loss was $4.5 million, or $0.28 per share, compared to a”

zSpace, Inc. reported the fiscal quarter ended March 31, 2026 results: revenue $5.3 million.

“Revenue in the first quarter of 2026 was $5.3 million compared to $6.8 million in the first quarter of 2025.”

GOLUB CAPITAL DIRECT LENDING CORP reported financial results for second fiscal quarter ended March 31, 2026.

“On May 14, 2026 in connection with the release of its financial results for its second fiscal quarter ended March 31, 2026, Golub Capital Direct Lending Corporation is providing an earnings presentation to its shareholders of record as of March 31, 2026.”

FGI Industries Ltd. reported first quarter 2026 results: revenue $30.5 million, net income net loss attributable to shareholders of $1.0 million.

“of kitchen and bath products, today announced results for the first quarter 2026. FIRST QUARTER 2026 HIGHLIGHTS (As compared to the first quarter of 2025) ▪ Total revenue of $30.5 million, -8.2% y/y ▪ Gross profit of $8.2 million , -8.3% y/y ▪ Gross margin of 26.8% , 0 bps y/y ▪ Operating loss of $0.7 million and net loss attributable to shareholders of $1.0”

Toppoint Holdings Inc. reported first quarter ended March 31, 2026 results: revenue $4,106,943, net income $653,732, EPS $(0.03) per diluted share.

“Toppoint Holdings Inc. Reports First Quarter 2026 Financial Results Revenue Grows 8% Year-Over-Year to $4.1 Million; Import and Metal Verticals Deliver Strong Double-Digit Growth NORTH WALES, PA, May 13, 2026 (GLOBE NEWSWIRE) -- Toppoint Holdings Inc. (NYSE American: TOPP), a truckload services and solutions provider focused on the recycling export supply chain, today reported financial results for the first quarter ended March 31, 2026.”

XBP Global Holdings, Inc. reported the quarter ended March 31, 2026 results: revenue $197.1 million.

“First Quarter 2026 Highlights • Revenue totaled $197.1 million, a decline of 14.2% year-over-year on a pro forma basis”

Tempest Therapeutics, Inc. reported the quarter ended March 31, 2026 results: net income $27.7 million, EPS $2.53.

“Net loss and net loss per share for the quarter were $27.7 million and $2.53, respectively, compared to $10.9 million and $3.16, respectively, for the three months ended March 31, 2025.”

T Stamp Inc reported the three months ended March 31, 2026 results: revenue $757 thousand, net income $2.23 million, EPS $0.42 per share.

“Net recognized revenue for the three months ended March 31, 2026 was $757 thousand, an increase of 39% from $545 thousand for the corresponding period in 2025.”

BOSTON OMAHA Corp reported the three months ended March 31, 2025 results: revenue 27,730, net income (670), EPS (0.02).

“Net $ 10,973 $ 10,764 Broadband Services 10,750 10,320 Premiums Earned 5,457 5,564 Insurance Commissions 631 579 Investment and Other Income 438 503 Total Revenues 28,249 27,730 Depreciation and Amortization Expense 6,323 5,938 Net Loss from Operations (2,188 ) (798 ) Net Other Expense (1,037 ) (1,817 ) Net Loss Attributable to Common Stockholders $”

BOSTON OMAHA Corp reported the first quarter ended March 31, 2026 results: revenue 28,249, net income (2,149), EPS (0.07).

“Rentals, Net $ 10,973 $ 10,764 Broadband Services 10,750 10,320 Premiums Earned 5,457 5,564 Insurance Commissions 631 579 Investment and Other Income 438 503 Total Revenues 28,249 27,730 Depreciation and Amortization Expense 6,323 5,938 Net Loss from Operations (2,188 ) (798 ) Net Other Expense (1,037 ) (1,817 ) Net Loss Attributable to Common Stockholders”

Innventure, Inc. reported financial results for the quarter ended March 31, 2026.

“Innventure, Inc. (the “Company”) issued a press release announcing the Company’s financial results for the first quarter ended March 31, 2026”

Comstock Holding Companies, Inc. reported the first quarter ended March 31, 2026 results: revenue $17.4 million, net income $2.0 million, EPS $0.19.

“--- q126earningsreleasefinal Comstock Reports First Quarter 2026 Results Revenue growth of 38% highlights strong first quarter for CHCI Q1 2026 • Revenue increased 38% to $17.4 million • Net income increased 25% to $2.0 million • Adjusted EBITDA increased 6% to $2.2 million Managed Portfolio • 24 additional AUM vs. prior year ◦”

COMSCORE, INC. reported the quarter ended March 31, 2026 results: revenue $85.3 million, net income $6.2 million net loss, EPS $(0.41) per share.

“evaluating media across platforms, today reported financial results for the quarter ended March 31, 2026. Business and Financial Highlights • Revenue for the first quarter was $85.3 million compared to $85.7 million in Q1 2025 ◦ 30% growth in cross-platform solutions, driven by Proximic and CCR and continued adoption of our cross-platform content measurement”

Odysight.ai Inc. reported the three months ended March 31, 2026 results: revenue $82 thousand.

“Revenues were $82 thousand, compared to approximately $2.1 million for the three months ended March 31, 2025.”

Bio Green Med Solution, Inc. reported first quarter ended March 31, 2026 results: revenue $0.8 million, net income Net loss for the three months ended March 31, 2026, was $0.2 million.

“have successfully transitioned our operations to focus on fire safety protection and distribution, and we are encouraged by the early momentum in this business, which generated $0.8 million in product revenue during the quarter.” “Our team has also made significant strides in strengthening our cost structure. General and administrative expenses declined by”

AleAnna, Inc. reported first quarter of 2026 results: revenue $8.9 million, net income $3.4 million.

“and future strategic initiatives. Financial and Operational Update Following production ramp-up and stabilization at the Longanesi field during 2025, the Company recognized $8.9 million of revenue during the first quarter of 2026 from sales of its share of production from the Longanesi field. During the first quarter, AleAnna generated net income of $3.4 million”

GameSquare Holdings, Inc. reported three months ended March 31, 2026 results: revenue $14.5 million, net income Net loss from continuing operations of $17.6 million. Guidance reaffirmed.

“to the risks and uncertainties described below,” Kenna concluded. Reported results for the three months ended March 31, 2026, compared to March 31, 2025 (unaudited) ● Revenue of $14.5 million, compared to $7.4 million ● Gross profit of $5.6 million, compared to $3.2 million ● Gross margin of 38.4%, compared to 42.5% ● Net loss from continuing operations of $17.6”

UNITED STATES ANTIMONY CORP reported first quarter ended March 31, 2026 results: revenue $6.8 million, net income $11.3 million, EPS $(0.08) per diluted share. Guidance reaffirmed.

“of War (“DoW”) Grant Milestones for Thompson Falls Expansion First Two Delivery Notices under the $245 MM Defense Logistics Agency (“DLA”) Contract Completed Q1 2026 Revenues of $6.8 Million; Net Loss of $11.3 Million, or $(0.08) per Diluted Share Post-Quarter Equity Issuances Generated $48.6 Million in Gross Proceeds Reiterates Full-Year 2026 Gross Revenue Guidance”

HARTE HANKS INC reported for the first quarter ended March 31, 2026 results: revenue $37.3 million, net income Net loss was $0.6 million, or $0.08 per basic and diluted share, EPS $0.08 per basic and diluted share.

“EBITDA throughout 2026.” First Quarter Highlights • The Company ended the quarter with a cash balance of $4.5 million at March 31, 2026. • Total revenues for Q1 2026 were $37.3 million, down 10.3% compared to $41.6 million in Q1 2025. • Operating loss was $768 thousand compared to a loss of $40 thousand in the same quarter in the prior year. • Net loss was $0.6”

First Tracks Biotherapeutics, Inc. reported the first quarter ended March 31, 2026 results: net income Net loss was $50.5 million for the three months ended March 31, 2026.

“On May 14, 2026, First Tracks Biotherapeutics, Inc. (“First Tracks”) issued a press release announcing its financial results for the three months ended March 31, 2026. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.”

Research Solutions, Inc. reported third quarter ended March 31, 2026 results: revenue $12.1 million, net income $860,000, EPS $0.03 per diluted share.

“platform, reported financial results for its fiscal third quarter ended March 31, 2026. Fiscal Third Quarter 2026 Summary (compared to prior-year quarter) · Total revenue of $12.1 million, compared to $12.7 million in the prior-year period. · Annual Recurring Revenue (“ARR”) up 8.5% to $22.1 million, which includes approximately $15.7 million of B2B recurring”

GeoVax Labs, Inc. reported the quarter ended March 31, 2026 results: net income $5.3 million.

“Net loss for the three months ended March 31, 2026, was $5.3 million”

Fortress Biotech, Inc. reported the first quarter ended March 31, 2026 results: net income $108.4 million, or $3.44 per common share (basic) and $2.82 per common share (diluted).

“Fortress’ consolidated net income attributable to common stockholders for the first quarter of 2026 was $108.4 million, or $3.44 per common share (basic) and $2.82 per common share (diluted)”

FARADAY FUTURE INTELLIGENT ELECTRIC INC. updated its first quarter ended March 31, 2026 guidance (raised).

“issued a press release in which the Company provided certain first quarter 2026 financial results, as well as its 2026 outlook. The full text of the press release is furnished herewith as Exhibit 99.1”

York Space Systems Inc. reported the fiscal quarter ended March 31, 2026 results: revenue $ 116,343, net income (114,842).

“York Space Systems Inc. (NYSE: YSS) (York) today announced financial results for the quarter ended March 31, 2026. ($ in thousands, except percentages) For the three months ended March 31, 2026 2025 % Change Revenue $ 116,343 $ 106,252 9 % Gross profit 22,150 24,602 (10 %) Net loss (114,842) (11,729) 879 %”

Cue Biopharma, Inc. reported the quarter ended March 31, 2026 results: revenue $5.7 million, net income Net loss ... $5.2 million, EPS $(1.08) per common share – basic and diluted.

“to the FDA in the second half of 2026 • Phase 1 first-in-human study expected to be initiated by year-end 2026. First Quarter 2026 Financial Results First quarter revenue was $5.7 million compared to $0.4 million in the first quarter of 2025. The revenue earned during the three months ended March 31, 2026 was related to the Boehringer Ingelheim collaboration and”

VOLITIONRX LTD reported the first quarter 2026 results: revenue $1.0 million.

“pillars; our laser focus is on executing licensing agreements and we will update you as they progress.” 1 Financial Highlights · Revenue for the first quarter was approximately $1.0 million, compared to $0.2 million for the same period in 2025. · Operating loss was down 3% for the quarter versus the comparable quarter in 2025. · Net cash used in operating activities”

TMC the metals Co Inc. reported first quarter ended March 31, 2026 results: net income Net loss of $20.6 million, EPS net loss per share of $0.05.

“On May 14, 2026, TMC the metals company Inc. (the “Company”) issued a press release announcing its results for the first quarter ended March 31, 2026 and providing a business update.”

Prairie Operating Co. reported first quarter ended March 31, 2026 results: revenue $83.4 million.

“for the first quarter ended March 31, 2026. Recent Key Highlights • Total production of 2.1 MMBoe, or approximately 23,200 Boe/d, with 72% liquids (48% oil). • Total revenue of $83.4 million, an increase of over 500% quarter-over-quarter • Adjusted EBITDA (1) of $37.2 million, an increase of over 600% quarter-over-quarter. • Delivered strong operational execution,”

SOUNDTHINKING, INC. reported first quarter ended March 31, 2026 results: revenue $24.2 million, net income GAAP net loss totaled $7.0 million. Guidance reaffirmed.

“SoundThinking, Inc. Reports First Quarter 2026 Financial Results Revenues Decreased 15% to $24.2 Million”

RenovoRx, Inc. reported the first quarter ended March 31, 2026 results: revenue $563,000.

“herein by reference. --- EX-99.1 (EX-99.1) --- EX-99.1 RenovoRx Reports Record First Quarter 2026: Increasing Revenue by 136% Quarter-over-Quarter Q1 2026 Revenue of $563,000 Totals Over 50% of Full Year 2025 Total Revenue Active Commercial Cancer Center Customers Expand to 16 with Growing Sales Pipeline, Accelerating Adoption of the TAMPTM Therapy”

KULR Technology Group, Inc. reported the first quarter ended March 31, 2026 results: revenue $4,846,430, net income $28,119,844, EPS $0.61 per share.

“and telecom infrastructure OEMs, today announced its financial results for the first quarter 2026. First Quarter 2026 Financial Results: Revenues: Revenue increased 98% to $4,846,430 in the first quarter ended March 31, 2026, from $2,448,606 reported in the same year-ago period. Gross Margins: Gross margin was 29% in the first quarter ended March 31, 2026,”

Eton Pharmaceuticals, Inc. reported the quarter ended March 31, 2026 results: revenue $24.3 million, EPS $0.05. Guidance raised.

“Q1 2026 product sales of $24.3 million, representing 73% growth over Q1 2025 ● Raising full year revenue guidance - now expect 2026 revenue to exceed $120 million, up from previous guidance of $110 million ● Q1 2026 fully diluted GAAP EPS of $0.05”

Calidi Biotherapeutics, Inc. reported the first quarter ended March 31, 2026 results: net income net loss attributable to common stockholders of $4.4 million, or $0.43 per share, EPS $0.43 per share.

“The Company reported a net loss attributable to common stockholders of $4.4 million, or $0.43 per share, for the three months ended March 31, 2026, compared to a net loss attributable to common stockholders of $5.0 million, or $2.21 per share, for the same period in 2025.”

INTERPACE BIOSCIENCES, INC. reported first quarter ended March 31, 2026 results: revenue $9.0 million, net income $0.8 million. Guidance reaffirmed.

“Interpace generated Q1 2026 revenue of $9.0 million on 12% year-over-year thyroid revenue growth, delivered $0.8 million of income from continuing operations”

BARFRESH FOOD GROUP INC. reported first quarter ended March 31, 2026 results: revenue $5.6 million, net income $661,000.

“Barfresh Announces First Quarter 2026 Results First Quarter 2026 Revenue Surpasses Outlook, Rising 92% to a Record Quarterly $5.6 million”

MapLight Therapeutics, Inc. reported first quarter ended March 31, 2026 results: net income Net loss was $60.7 million.

“On May 14, 2026, MapLight Therapeutics, Inc. (the "Company") issued a press release announcing its financial results for the first quarter ended March 31, 2026.”

DAWSON GEOPHYSICAL CO reported first quarter ended March 31, 2026 results: revenue $32.5 million, net income $7.7 million, EPS $0.25 per share.

“DWSN) (the “Company”) today reported unaudited financial results for its first quarter ended March 31, 2026. ​ First quarter 2026 Highlights ​ ● Recognized fee revenue of $32.5 million, an 113% increase over the first quarter of 2025 ● Net income of $7.7 million, $0.25 per share ● Generated Adjusted EBITDA of $10.9 million, an 364% increase over the first”

Laird Superfood, Inc. reported first quarter ended March 31, 2026 results: revenue $13.9 million, net income $1.8 million, EPS $0.12 per basic share ($0.11 per diluted share).

“Laird Superfood Reports First Quarter 2026 Financial Results Net Sales of $13.9 million for First Quarter 2026, growth of 20% year-over-year.”

Cardiff Oncology, Inc. reported financial results for first quarter ended March 31, 2026.

“On May 14, 2026, Cardiff Oncology, Inc. issued a press release announcing a business update and financial results for the first quarter ended March 31, 2026.”